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of neointima formation and reduction of vascular smooth muscle 
cell proliferation and migration (Peyton et al., 2012). In microvascu-
lar endothelial cells, low (“physiological”) bilirubin concentrations 
induce apoptosis, which is exacerbated under hyperglycemic condi-
tions. Endothelial cells of the blood-brain barrier are particularly 
sensitive to these effects of bilirubin (Kapitulnik et al., 2012).
ConClusion
Bilirubin, which has been considered for decades to be a toxic waste 
product of heme catabolism, is now recognized as an endogenous 
cytoprotective compound at low (“physiological”) concentrations. 
However, its protective effects have been demonstrated in vitro, 
mainly in peripheral tissues, while its neurotoxicity remains 
unchallenged.
Although moderately elevated plasma bilirubin levels (as 
those of subjects with Gilbert syndrome) have been shown in 
retrospective and prospective clinical studies to be associated 
with a decreased risk of cardiovascular diseases (Vitek, 2012), 
there is still no general concensus in applying this knowledge in 
manipulating bilirubin levels for the prevention of cardiovascular 
and associated diseases. Stimulation of biliverdin reduction and/
or inhibition of bilirubin conjugation are highly questionable 
with regards to their safety in humans, particularly in the sce-
nario of a life-long treatment. We hope that the work presented 
in this Research Topic will stimulate further basic and clinical 
research in the area of bile pigments and its pathological as well 
as therapeutic implications.
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Degradation of heme involves its conversion to biliverdin by heme 
oxygenase followed by reduction of biliverdin to bilirubin by bili-
verdin reductase. There is ample evidence for the role of heme 
oxygenase in protecting cells from the toxic effects of heme, as well 
as for the pleiotropic functions of biliverdin reductase in cell sign-
aling and regulation of gene expression. This enzyme plays a major 
role in glucose uptake and the stress response. Bilirubin has been 
shown to behave as a “double-edged sword.” It can exert either 
cytotoxic or cytoprotective effects, depending on the blood and/or 
tissue concentration of its free fraction, the nature of the target cell 
or tissue, and the cellular redox state. The central nervous system 
is particularly sensitive to the neurotoxic effects of bilirubin. Its 
antioxidant effect is the basis for the proposed cardioprotective 
effect of bilirubin in humans with moderate hyperbilirubinemia, 
as is the case in subjects with the Gilbert syndrome.
This Research Topic forum is intended to serve as a platform for 
updating information and presenting advances in basic and clinical 
research in the above and related subjects. The topic is discussed 
by leading experts in the field of bile pigments, and presented in 
15 Reviews, 3 Original Research articles and 1 Opinion article. It 
covers important aspects related to the enzymes involved in the 
heme catabolic pathway: the role of heme oxygenase in inflamma-
tion and fibrosis (Lundvig et al., 2012) as well as in atherosclerosis 
(Araujo et al., 2012) and immune-mediated inflammatory diseases 
(Larsen et al., 2012), the regulation of cell signaling by biliverdin 
reductase and its peptide fragments (Gibbs et al., 2012), and the 
regulation of bilirubin clearance (Bock, 2011).
The role of glial cells and inflammation in bilirubin neurotoxic-
ity (Brites, 2012) and the transport and metabolism of bilirubin at 
blood-brain interfaces and neural cells (Gazzin et al., 2012) illus-
trate the complex nature of bilirubin-induced brain damage. The 
effects of bilirubin vary with age (Dennery, 2012), and metallopor-
phyrins have been suggested to reduce excessive hyperbilirubinemia 
and brain damage in newborns (Schulz et al., 2012).
The regulatory properties of bile pigments and the role of biliver-
din reductase in mediating their antioxidative (Jansen and Daiber, 
2012) and anti-inflammatory effects (Wegiel and Otterbein, 2012), 
and their role in aging and age-related diseases (Kim and Park, 2012), 
are only part of the known protective functions of bile pigments. 
Bilirubin displays antiviral activity (Santangelo et al., 2012; Schmidt 
et al., 2012), ameliorates renal hemodynamics and blood pressure 
in an animal model of hypertension (Stec et al., 2012), and has ben-
eficial effects in pulmonary and vascular diseases (Ryter, 2012). The 
protective effects of bilirubin in the vasculature include inhibition 
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